An advantageous route to oxcarbazepine (Trileptal) based on palladium-catalyzed arylations free of transmetallating agents

Organic Letters

Volumn 7, Issue 22, 2005, Pages 4787-4789

  Carril, Mónica ^a   SanMartin, Raul ^a   Churruca, Fátima ^a   Tellitu, Imanol ^a   Domínguez, Esther ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIBROMOBENZENE; 1,2-DIBROMOBENZENE; 2 AMINOACETOPHENONE; 2-AMINOACETOPHENONE; ACETOPHENONE DERIVATIVE; ANTICONVULSIVE AGENT; BROMOBENZENE; CARBAMAZEPINE; DRUG DERIVATIVE; KETONE; OXCARBAZEPINE; PALLADIUM; WATER;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS; TIME;

ACETOPHENONES; ANTICONVULSANTS; BROMOBENZENES; CARBAMAZEPINE; CATALYSIS; KETONES; MOLECULAR STRUCTURE; PALLADIUM; TIME FACTORS; WATER;

EID: 27644566715     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol051291p     Document Type: Article

References (19)

1. Clemens, B.; Menes, A.; Nagy, Z. Acta Neurol. Scand. 2004, 109, 324.
2. (a) Lande, R. G. Int. J. Psychiatry Clin. Pract. 2004, 8, 37.
3. (b) Hopwood, M.; Manning, D. WO Patent Application 2004035041, 2004; Chem. Abstr. 2004, 140, 363050.
4. Milanese, A. PCT Int. Appl. WO 9621649, 1996; Chem. Abstr. 1996, 125, 195448.
5. (a) Lohse, O.; Beutler, U.; Fünfschilling, P.; Furet, P.; France, J.; Kauffmann, D.; Penn, G.; Zaugg, W. Tetrahedron Lett. 2001, 42, 385.
6. (b) Kauffmann, D.; Fünfschilling, P.; Beutler, U.; Hoehn, P.; Lohse, O.; Zaugg, W. Tetrahedron Lett. 2004, 45, 5275.
7. (a) Hernández, S.; SanMartin, R.; Tellitu, I.; Domínguez, E. Org. Lett. 2002, 4, 1591.
8. (b) Churruca, F.; SanMartin, R.; Carril, M.; Tellitu, I.; Domínguez, E. Tetrahedron 2004, 60, 2393.
9. Initial attempts to perform α-arylation directly from aminoketone 3 gave negligible results.
10. All α-arylation assays performed on substrate 6b provided, apart from null or very low yields of target intermediate 7b, variable amounts of N-arylated/deprotected product 9. (Chemical Equation Presented)
11. (a) Palucki, M.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 11108.
12. (b) Hamann, B. C.; Hartwig, J. F. J. Am. Chem. Soc. 1997, 119, 12382.
13. For one of the few examples in which Xantphos is used for the α-arylation of carbonyl compounds, see: Fox, J. M.; Huang, X.; Chieffi, A.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360.
14. (a) Ueda, M.; Nishimura, M.; Miyaura, N. Synlett 2000, 856.
15. See also: (b) Catalytic Organic Reactions in Water (special issue); Adv. Synth. Catal. 2002, 3-4.
16. (c) Fan, Q.-H.; Li, Y.-M.; Chan, A. S. C. Chem. Rev. 2002, 102, 3385-3466.
17. (d) Genet, J. P.; Savignac, M. J. Organomet. Chem. 1999, 576, 305-317.
18. Some assays performed to effect α-arylation of N-tosylated derivative 6a provided traces of the so-cyclized azepinone. Although strictly preliminary, we consider such results as promising.
19. Novartis Pharma claims a 70-80% yield for the same carbamoylation reaction, but reference the procedure reported in ref 3, in which only a 35% is obtained. See also ref 4.